CONTRIBUTION OF ANTICHOLINERGIC MEDICATION TO SYMPTOM CHANGE IN SCHIZOPHRENIA

被引：0
|
作者：
DEQUARDO, JR
KLOSS, RJ
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 1993年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [1] CONTRIBUTION OF ANTICHOLINERGIC MEDICATION TO SYMPTOM CHANGE IN SCHIZOPHRENIA - REPLY
    SERBAN, G
    JOURNAL OF CLINICAL PSYCHIATRY, 1993, 54 (09) : 357 - 357
  • [2] EFFECTS OF ANTICHOLINERGIC MEDICATION ON MEMORY IN SCHIZOPHRENIA
    STRAUSS, ME
    REYNOLDS, KS
    JAYARAM, G
    TUNE, LE
    SCHIZOPHRENIA RESEARCH, 1990, 3 (02) : 127 - 129
  • [3] Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden
    Joshi, Yash B.
    Molina, Juan L.
    Braff, David L.
    Green, Michael F.
    Gur, Ruben C.
    Gur, Raquel E.
    Nuechterlein, Keith H.
    Stone, William S.
    Greenwood, Tiffany A.
    Lazzeroni, Laura C.
    Radant, Allen D.
    Silverman, Jeremy M.
    Sprock, Joyce
    Sugar, Catherine A.
    Tsuang, Debby W.
    Tsuang, Ming T.
    Turetsky, Bruce I.
    Swerdlow, Neal R.
    Light, Gregory A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (07): : 519 - 523
  • [4] RELATION OF NEUROLEPTIC AND ANTICHOLINERGIC MEDICATION TO COGNITIVE FUNCTIONS IN SCHIZOPHRENIA
    SPOHN, HE
    STRAUSS, ME
    JOURNAL OF ABNORMAL PSYCHOLOGY, 1989, 98 (04) : 367 - 380
  • [5] Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
    Joshi, Yash B.
    Thomas, Michael L.
    Braff, David L.
    Green, Michael F.
    Gur, Ruben C.
    Gur, Raquel E.
    Nuechterlein, Keith H.
    Stone, William S.
    Greenwood, Tiffany A.
    Lazzeroni, Laura C.
    MacDonald, Laura R.
    Molina, Juan L.
    Nungaray, John A.
    Radant, Allen D.
    Silverman, Jeremy M.
    Sprock, Joyce
    Sugar, Catherine A.
    Tsuang, Debby W.
    Tsuang, Ming T.
    Turetsky, Bruce, I
    Swerdlow, Neal R.
    Light, Gregory A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (09): : 838 - 847
  • [6] The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
    Ang, Mei San
    Rashid, Nur Amirah Abdul
    Lam, Max
    Rapisarda, Attilio
    Kraus, Michael
    Keefe, Richard S. E.
    Lee, Jimmy
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 651 - 656
  • [7] Pathways From Genes to Functioning: Integrating Genetic Risk, Neurophysiology, Anticholinergic Medication Burden, Cognition, and Symptom Contributions to Disability in Schizophrenia
    Joshi, Yash
    Thomas, Michael
    Bigdeli, Tim
    Molina, Juan
    Braff, David
    Swerdlow, Neal
    Light, Gregory
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 366 - 367
  • [8] Pathways From Genes to Functioning: Integrating Genetic Risk, Neurophysiology, Anticholinergic Medication Burden, Cognition, and Symptom Contributions to Disability in Schizophrenia
    Joshi, Yash
    Thomas, Michael
    Bigdeli, Tim
    Molina, Juan
    Braff, David
    Swerdlow, Neal
    Light, Gregory
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 366 - 367
  • [9] The cholinergic system in schizophrenia reconsidered: Anticholinergic modulation of sleep and symptom profiles
    Tandon, R
    Taylor, SF
    DeQuardo, JR
    Eiser, A
    Jibson, MD
    Goldman, M
    NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) : S189 - S202
  • [10] The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom Profiles
    Rajiv Tandon
    Stephan F Taylor
    John R DeQuardo
    Alan Eiser
    Michael D Jibson
    Mona Goldman
    Neuropsychopharmacology, 1999, 21 : S189 - S202
12345